Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia
Sign Up to like & getrecommendations! Published in 2018 at "European Respiratory Journal"
DOI: 10.1183/13993003.01482-2018
Abstract: Sarcoidosis is a systemic disorder of unknown aetiology characterised by the formation of non-caseating epithelioid granulomas in involved organs. Although a spontaneous remission is frequent, up to 28–53% of patients may follow a persistent active… read more here.
Keywords: dramatic response; response refractory; ruxolitinib patient; refractory sarcoidosis ... See more keywords
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
Sign Up to like & getrecommendations! Published in 2022 at "Respiratory Research"
DOI: 10.1186/s12931-022-01971-5
Abstract: Background Infliximab is a monoclonal antibody that binds and neutralizes circulating tumor necrosis factor-alpha, a key inflammatory cytokine in the pathophysiology of sarcoidosis. Despite the paucity of randomized clinical trials, infliximab is often considered a… read more here.
Keywords: infliximab; treatment; sarcoidosis; therapy refractory ... See more keywords